Literature DB >> 1113379

Complementation of human adenovirus type 5 ts mutants by human adenovirus type 12.

J Williams, H Young, P Austin.   

Abstract

Temperature-sensitive mutants of type 5 adenovirus belonging to eight complementation groups were complemented in mixed infection by type 12 adenovirus, whereas mutants of 7 other groups were not enhanced. In some crosses, phenotypic mixing took place. No evidence of recombination between type 5 ts mutants and type 12 was found.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1113379      PMCID： PMC354504     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  19 in total

1.  INFECTION WITH ADENOVIRUS TYPE 12.

Authors:  M S PEREIRA; F O MACCALLUM
Journal:  Lancet       Date:  1964-01-25       Impact factor: 79.321

2.  Mapping of base sequence heterologies between genomes from different adenovirus serotypes.

Authors:  C F Garon; K W Berry; J C Hierholzer; J A Rose
Journal:  Virology       Date:  1973-08       Impact factor: 3.616

Review 3.  Oncogenic viruses.

Authors:  M Green
Journal:  Annu Rev Biochem       Date:  1970       Impact factor: 23.643

4.  Mosaics of capsid components produced by cocultivation of certain human adenoviruses in vitro.

Authors:  E Norrby; Y Gollmar
Journal:  Virology       Date:  1971-05       Impact factor: 3.616

Review 5.  Adenoviruses: the nature of the virion and of controlling factors in productive or abortive infection and tumorigenesis.

Authors:  R W Schlesinger
Journal:  Adv Virus Res       Date:  1969       Impact factor: 9.937

6.  Transcription and replication of viral deoxyribonucleic acid in cells coinfected with adenovirus types 2 and 12.

Authors:  S Mak
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

7.  Enhancement of adenovirus plaque formation on HeLa cells by magnesium chloride.

Authors:  J F Williams
Journal:  J Gen Virol       Date:  1970-12       Impact factor: 3.891

8.  Induction of DNA synthesis by adenoviruses in contact-inhibited hamster cells.

Authors:  H Shimojo; T Yamashita
Journal:  Virology       Date:  1968-11       Impact factor: 3.616

9.  Isolation of temperature-sensitive mutants of adenovirus type 5.

Authors:  J F Williams; M Gharpure; S Ustacelebi; S McDonald
Journal:  J Gen Virol       Date:  1971-05       Impact factor: 3.891

10.  Selection and preliminary characterization of temperature-sensitive mutants of type 5 adenovirus.

Authors:  M J Ensinger; H S Ginsberg
Journal:  J Virol       Date:  1972-09       Impact factor: 5.103
View more
  7 in total

1.  Isolation and characterization of temperature-sensitive mutants of adenovirus type 7.

Authors:  J Praszkier; H S Ginsberg
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

2.  Molecular evolution of human species D adenoviruses.

Authors:  Christopher M Robinson; Donald Seto; Morris S Jones; David W Dyer; James Chodosh
Journal:  Infect Genet Evol       Date:  2011-05-05       Impact factor: 3.342

3.  Helper function of adenovirus 2 for adenovirus 41 antigen synthesis in semi-permissive and non-permissive cells.

Authors:  C T Tiemessen; A H Kidd
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

4.  Comparison of late mRNA splicing among class B and class C adenoviruses.

Authors:  B A Kilpatrick; R E Gelinas; T R Broker; L T Chow
Journal:  J Virol       Date:  1979-06       Impact factor: 5.103

5.  Complementation of adenovirus type 5 host range mutants by adenovirus type 12 in coinfected HeLa and BHK-21 cells.

Authors:  D T Rowe; F L Graham
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

6.  Recombinant human adenoviruses containing hybrid adenovirus type 5 (Ad5)/Ad12 E1A genes: characterization of hybrid E1A proteins and analysis of transforming activity and host range.

Authors:  T Jelinek; F L Graham
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

7.  Characterization of a temperature-sensitive mutant of human adenovirus type 7.

Authors:  M K Estes; J S Butel
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.